RxDoctor Payments Data

John Alessi, DO

Family Medicine · Prescott Valley, AZNPI 1629099387

Payments from drug & device makers

$401in general payments, 2019–2025

Across 24 payments — averaging $16.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$54
  • Amgen$47
  • Aimmune Therapeutics, Inc.$43
  • GSK$39
  • Johnson & Johnson$37
  • Sanofi-aventis U.S. LLC$34
  • plus $147 from 9 others

What the payments were for

  • Food & beverage$401100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$401 in reported general payments places this provider in the 55th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$275,100
Medicare patients
569
Services billed
5,917

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide127$158,185
EliquisApixaban108$134,160
CreonLipase/Protease/Amylase25$99,854
OzempicSemaglutide73$83,152
FarxigaDapagliflozin Propanediol37$43,480
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$26,387
XareltoRivaroxaban15$24,841
JardianceEmpagliflozin15$19,003
Spiriva HandihalerTiotropium Bromide15$18,376
MyrbetriqMirabegron14$15,928
JanuviaSitagliptin Phosphate12$14,592
Soliqua 100-33Insulin Glargine/Lixisenatide14$13,274
Breo ElliptaFluticasone/Vilanterol15$11,939
LinzessLinaclotide17$11,703
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$11,163

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$54$158,185127 claims
AbbVieCreon, Linzess, Synthroid$15$113,90778 claims
Novo NordiskOzempic$17$83,15273 claims
AstraZenecaFarxiga, Symbicort$24$49,12848 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$39$42,33256 claims
Johnson & JohnsonXarelto$37$24,84115 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus$34$16,34329 claims
MerckJanuvia$15$14,59212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Prescott Valley

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →